In the latest market close, CRISPR Therapeutics AG (CRSP) reached $39.11, with a +1.48% movement compared to the previous day. This move lagged the S&P 500's daily gain of 2.03%. At the same time, the ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Getting custom ringtones isn’t as popular as it once was, but that’s likely because it’s easier than ever to find them. Surprisingly, the market for Android apps to find ringtones ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Previously, we relied on local meteorologists for the weekly weather forecast. Nowadays, with smartphones, we have access to the latest weather forecasts 24/7 right from our pockets. Whether you ...

CRISPR–Cas, a bacterial defence system that recognizes and slashes specific sequences in viral genomes, gave scientists the power to delete or edit genes with remarkable precision. Developed in ...

Some natural methods can help relieve a dry, itchy scalp at home, including rinsing with apple cider vinegar or applying oils and other moisturizing ingredients. Dry scalp can have a number of ...

In 2019, he raised $15 million in seed funding to use genetic technology such as CRISPR for work in conservation biology. After founding Colossal two years later, he garnered attention for ...

The CRISPR Market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.1% from 2024 ...